Inovio Pharmaceuticals Inc (INO) — Financial Flexibility Index
Inovio Pharmaceuticals Inc (INO) has a Financial Flexibility Index of -0.28x as of September 2025. Free cash flow of $-21.51 Million (operating CF $-21.57 Million minus capex $67.95K) represents 0% of total liabilities ($77.11 Million). Check INO strategic assets to equity ratio to assess the company's strategic physical and investment asset allocation.
Financial Flexibility Index
Free Cash Flow
Total Liabilities
Capital Expenditures
Inovio Pharmaceuticals Inc Financial Flexibility Index (1998–2024)
Historical Financial Flexibility Index trend for Inovio Pharmaceuticals Inc across 27 annual periods. See INO current assets to equity ratio to evaluate short-term liquidity relative to the company's equity base.
Annual Financial Flexibility Index for Inovio Pharmaceuticals Inc (1998–2024)
Year-by-year free cash flow to debt coverage for Inovio Pharmaceuticals Inc. For the full company profile including market capitalisation, see INO market cap.
| Year | Flexibility Index | Free Cash Flow (USD) | Operating CF | Total Liabilities | YoY Change |
|---|---|---|---|---|---|
| 2024 | -2.32x | $-103.59 Million | $-104.08 Million | $44.69 Million | ▼ -0.2% |
| 2023 | -2.31x | $-124.04 Million | $-124.37 Million | $53.60 Million | ▼ -35.6% |
| 2022 | -1.71x | $-215.25 Million | $-216.22 Million | $126.17 Million | ▲ +23.4% |
| 2021 | -2.23x | $-214.48 Million | $-215.71 Million | $96.27 Million | ▲ +0.7% |
| 2020 | -2.24x | $-176.46 Million | $-177.98 Million | $78.63 Million | ▼ -221.0% |
| 2019 | -0.70x | $-96.86 Million | $-97.85 Million | $138.55 Million | ▲ +56.9% |
| 2018 | -1.62x | $-71.47 Million | $-73.55 Million | $44.08 Million | ▼ -37.1% |
| 2017 | -1.18x | $-52.92 Million | $-63.21 Million | $44.75 Million | ▼ -1.5% |
| 2016 | -1.16x | $-58.62 Million | $-62.56 Million | $50.33 Million | ▼ -357.2% |
| 2015 | -0.25x | $-9.66 Million | $-12.44 Million | $37.91 Million | ▲ +81.9% |
| 2014 | -1.40x | $-28.44 Million | $-29.82 Million | $20.25 Million | ▼ -226.9% |
| 2013 | -0.43x | $-15.20 Million | $-15.38 Million | $35.38 Million | ▲ +80.0% |
| 2012 | -2.15x | $-22.07 Million | $-22.31 Million | $10.28 Million | ▼ -45.1% |
| 2011 | -1.48x | $-19.59 Million | $-19.76 Million | $13.24 Million | ▼ -14.0% |
| 2010 | -1.30x | $-11.63 Million | $-11.94 Million | $8.97 Million | ▼ -81.3% |
| 2009 | -0.72x | $-13.92 Million | $-14.08 Million | $19.44 Million | ▼ -35.0% |
| 2008 | -0.53x | $-10.54 Million | $-11.13 Million | $19.88 Million | ▲ +57.4% |
| 2007 | -1.24x | $-10.87 Million | $-11.51 Million | $8.74 Million | ▼ -172.6% |
| 2006 | -0.46x | $-5.68 Million | $-7.04 Million | $12.45 Million | ▲ +79.2% |
| 2005 | -2.19x | $-12.05 Million | $-12.34 Million | $5.51 Million | ▼ -76.5% |
| 2004 | -1.24x | $-6.70 Million | $-6.80 Million | $5.40 Million | ▲ +45.5% |
| 2003 | -2.28x | $-2.69 Million | $-2.75 Million | $1.18 Million | ▲ +15.3% |
| 2002 | -2.69x | $-4.55 Million | $-4.96 Million | $1.69 Million | ▲ +44.6% |
| 2001 | -4.85x | $-8.11 Million | $-8.37 Million | $1.67 Million | ▲ +8.9% |
| 2000 | -5.33x | $-8.50 Million | $-8.79 Million | $1.60 Million | ▼ -100.3% |
| 1999 | -2.66x | $-5.80 Million | $-6.30 Million | $2.18 Million | ▲ +31.2% |
| 1998 | -3.87x | $-5.80 Million | $-6.30 Million | $1.50 Million | — |